UK sees an upsurge in measles, declares it as ‘public health risk’
HQ Team January 20, 2024: Measles is fast witnessing a surge across the world and the latest region reporting an upsurge is central.
Drugs
Health
Medical
Drugs
Medical
Pharma
GSK offloads 300 million shares in Haleon for $1.2 billion
HQ Team January 19, 2024: GSK is giving up more of its stake in Haleon, the consumer health business the British pharma giant.
Drugs
Health
Medical
Study finds gene variants tied to higher incidents of glaucoma in Africans
HQ Team January 19, 2024: A comprehensive multicohort genome-wide association study (GWAS), led by researchers at the Perelman School of Medicine at the.
Drugs
Medical
Pharma
FDA green lights DermaSensor’s skin cancer detection device in the US
HQ Team January 18, 2024: The FDA has approved US-based DermaSensor Inc.’s handheld wireless skin cancer detection device that is powered by artificial.
Drugs
Health
Medical
Global deaths from fungal disease double, account for 6.8% of overall
HQ team January 16, 2024: A recent study has found that global deaths from fungal diseases have doubled in the past decade. The.
Drugs
Health
Pharma
Opinion: Vaccine for malaria took a while, but it’s worth the wait
By K. Leelamoni January 16, 2024: Vaccination is a simple, safe and effective method of protecting the body against infectious diseases. Ever since.
Drugs
Medical
Pharma
Merck’s Keytruda receives FDA nod for cervical cancer treatment
HQ Team January 13, 2024: The U.S. Food and Drug Administration (FDA) has granted approval for the expanded use of Merck & Co’s.
Drugs
Medical
Pharma
Venture capitalists, scientists plan biomedical research unit for new drugs
HQ Team January 13, 2024: High-profile scientists and financiers are pooling resources to launch a biomedical research facility that they claim will offer.
Drugs
Health
Pharma
University of Oxford starts human trials to develop vaccine against Nipah virus
HQ Team January 11, 2023: The first human trials for a vaccine against Nipah virus have been started by the University of Oxford,.
Drugs
Health
Pharma
GSK Plc., to buy asthma drugmaker Aiolos Bio for $1.4 billion
HQ Team January 9, 2023: British drugmaker GSK Plc., will pay $1.4 billion to acquire Anglo-American biopharmaceutical company Aiolos Bio Inc., which makes.